Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,589.12
    -1,950.08 (-3.86%)
     
  • CMC Crypto 200

    1,257.86
    -100.15 (-7.38%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Global Pharmaceutical Analytical Testing Outsourcing Market to Reach $10.2 Billion by 2027

Abstract: - Global Pharmaceutical Analytical Testing Outsourcing Market to Reach $10. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Pharmaceutical Analytical Testing Outsourcing estimated at US$6.

New York, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pharmaceutical Analytical Testing Outsourcing Industry" - https://www.reportlinker.com/p06032490/?utm_source=GNW
4 Billion in the year 2020, is projected to reach a revised size of US$10.2 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Bioanalytical Testing, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Method Development & Validation segment is readjusted to a revised 6.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 6.4% CAGR
- The Pharmaceutical Analytical Testing Outsourcing market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.
- Stability Testing Segment to Record 5.8% CAGR
- In the global Stability Testing segment, USA, Canada, Japan, China and Europe will drive the 5.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$485.6 Million in the year 2020 will reach a projected size of US$723.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.2 Billion by the year 2027.

- Select Competitors (Total 40 Featured) -

  • Bioreliance

  • Boston Analytical

  • Charles River Laboratories International, Inc.

  • Dalton Pharma Services

  • Eurofins Scientific

  • Exova

  • Halo Pharma

  • Intertek Group PLC

  • Pace Analytical Services, LLC

  • Pharmaceutical Product Development, LLC

  • SGS SA

  • Toxikon, Inc.

  • West Pharmaceutical Services, Inc.

  • WuXi AppTec, Inc.




Read the full report: https://www.reportlinker.com/p06032490/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World 7-Year Perspective for Pharmaceutical Analytical
Testing Outsourcing by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Bioanalytical
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 4: World 7-Year Perspective for Bioanalytical Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 5: World Current & Future Analysis for Method Development &
Validation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 6: World 7-Year Perspective for Method Development &
Validation by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 7: World Current & Future Analysis for Stability Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World 7-Year Perspective for Stability Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Other Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 10: World 7-Year Perspective for Other Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 11: USA Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 12: USA 7-Year Perspective for Pharmaceutical Analytical
Testing Outsourcing by Service - Percentage Breakdown of Value
Sales for Bioanalytical Testing, Method Development &
Validation, Stability Testing and Other Services for the Years
2020 & 2027

CANADA
Table 13: Canada Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 14: Canada 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

JAPAN
Table 15: Japan Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 16: Japan 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

CHINA
Table 17: China Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 18: China 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

EUROPE
Table 19: Europe Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: Europe 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany, Italy,
UK and Rest of Europe Markets for Years 2020 & 2027

Table 21: Europe Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 22: Europe 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

FRANCE
Table 23: France Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 24: France 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

GERMANY
Table 25: Germany Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 26: Germany 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

ITALY
Table 27: Italy Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 28: Italy 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

UNITED KINGDOM
Table 29: UK Current & Future Analysis for Pharmaceutical
Analytical Testing Outsourcing by Service - Bioanalytical
Testing, Method Development & Validation, Stability Testing and
Other Services - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 30: UK 7-Year Perspective for Pharmaceutical Analytical
Testing Outsourcing by Service - Percentage Breakdown of Value
Sales for Bioanalytical Testing, Method Development &
Validation, Stability Testing and Other Services for the Years
2020 & 2027

REST OF EUROPE
Table 31: Rest of Europe Current & Future Analysis for
Pharmaceutical Analytical Testing Outsourcing by Service -
Bioanalytical Testing, Method Development & Validation,
Stability Testing and Other Services - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 32: Rest of Europe 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

ASIA-PACIFIC
Table 33: Asia-Pacific Current & Future Analysis for
Pharmaceutical Analytical Testing Outsourcing by Service -
Bioanalytical Testing, Method Development & Validation,
Stability Testing and Other Services - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 34: Asia-Pacific 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

REST OF WORLD
Table 35: Rest of World Current & Future Analysis for
Pharmaceutical Analytical Testing Outsourcing by Service -
Bioanalytical Testing, Method Development & Validation,
Stability Testing and Other Services - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 36: Rest of World 7-Year Perspective for Pharmaceutical
Analytical Testing Outsourcing by Service - Percentage
Breakdown of Value Sales for Bioanalytical Testing, Method
Development & Validation, Stability Testing and Other Services
for the Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 40
Read the full report: https://www.reportlinker.com/p06032490/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001